Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (23171)	7/14/1998 9:54:00 AM
From: Flagrante Delictu	Read Replies (2) \| Respond to of 32384

tonyt, tonyt, OFF TOPIC, >> How that post on #(sic) reply-3462385 could possibly be spun into an ' interview' is beyond belief. << What is beyond belief, is that anyone, who read the post, could fail to notice that the post quoted both Richard A. Heyman and Andres Negro-Vilar, the scientific honchos of LGND. In addition, for anyone ( such as Tonyt himself) to fail to notice the substantial detail about LGND & the background of retinoids & their actual or potential usage in the various indications mentioned in the article ,and also, to assume the reporter didn't acquire that information , in addition to the aforementioned quotes, as a result of an interview with LGND officials, is truly beyond belief. Why must you continue to subject your reasoning ability to the potential ridicule of our threadsters ?